Vote Scores
Filings read through

Fennec Pharmaceuticals Inc.: how funds voted at the meeting of 25 Jun 2024

Ticker
FENC
Meeting
Season
year to 30 June 2024
Filers reporting
113
Ballot items
4

113 filers on Form N-PX reported votes at the Fennec Pharmaceuticals Inc. meeting of 25 Jun 2024. The records fall into 4 ballot items. The page lists them in ballot order: items of the company first, then proposals from security holders. Each bar shows how the reporting filers split. It is not the result of the meeting.

This meeting is in the year to 30 June 2024. The latest season on file is the year to 30 June 2026. The page of Fennec Pharmaceuticals Inc. has the latest meeting.

If the reporting person has not received confirmation of the actual number of votes cast prior to filing a report on Form N-PX, the numbers reported may reflect the number of shares instructed to be cast. A reporting person is not required to amend a previously filed Form N-PX report if the reporting person subsequently receives confirmation of the actual number of votes cast.

The words of the SEC. Source: Form N-PX and its instructions, Special Instructions D.5 and D.8, copied on .

The words of this site: the filer writes each filing. The SEC does not say that it checked the votes. A lender does not vote shares that are on loan. A later filing (Form N-PX/A) can replace an earlier filing, and the site uses the latest.

The figures on this page count the filers that report on Form N-PX and the shares they reported. They do not count all votes cast at the meeting.

The page gives records. It gives no investment advice and no advice on how to vote.

Season on this page: year to 30 June 2024. Filings read through . How the figures are made

The ballot

ForAgainstAbstain, withhold or otherAmber tick: the part cast against management

  1. Item 1: Director elections

    5 nominees. 93.8% of the reported votes are for. 13 filers withheld from or voted against at least one nominee.

    370 vote records from 45 filers. 4 of the 45 filers that marked the item voted against management.

    • Positions of 21 fund families
    • For 19
    • Abstain or withhold 2
    • Against management 2
  2. Item 2: Advisory vote on executive pay (say-on-pay)

    155 vote records from 111 filers. 8 of the 109 filers that marked the item voted against management. 2 filers gave no management mark.

    • Positions of 30 fund families
    • For 29
    • Against 1
    • Against management 1
  3. Item 3: Audit-related items (auditor ratification)

    74 vote records from 45 filers. 0 of the 45 filers that marked the item voted against management.

    • Positions of 21 fund families
    • For 21
  4. Item 4: Shareholder proposals (not separable from the filings)

    • Proposed by a security holder
    • Several categories

    Filers described these proposals in different words that the site could not match, so they are shown together.

    2 vote records from 1 filer. 0 of the 1 filer that marked the item voted against management.

Positions of the fund families

A position is not the vote of each fund. The position of a family is the way most of the shares reported by its filers were voted. Funds of one family can vote in different ways.

KeyForAgainstAbstain or withholdSplit or no voteAgainst management

Fund families at Fennec Pharmaceuticals Inc., meeting of 25 Jun 2024Families in name order. "Abstain" includes withhold. "Split" includes no vote. "No report" means that no filer of the family listed the item.
Fund family2. Say-on-pay3. Auditor
AllianceBernsteinForNo report
BlackRock and iSharesForFor
BNY MellonForNo report
Brighthouse FundsForFor
Charles SchwabForFor
Columbia ThreadneedleForNo report
DWSForFor
EquitableForFor
FidelityForFor
Global XForFor
Goldman SachsForNo report
Guggenheim and RydexForFor
InvescoAgainst, against managementNo report
J.P. MorganForNo report
John Hancock and ManulifeForFor
Lincoln FinancialForFor
Morgan Stanley, Eaton Vance and CalvertForFor
NationwideForFor
Northern Trust and FlexSharesForFor
Nuveen and TIAAForFor
Pacific Life fundsForFor
PGIM and PrudentialForNo report
PrincipalForFor
ProShares and ProFundsForFor
Russell InvestmentsForNo report
SEIForNo report
State Street and SPDRForFor
T. Rowe PriceForFor
VanguardForFor
VoyaForFor

Questions

How many filers reported votes at the Fennec Pharmaceuticals Inc. meeting?
113 Form N-PX filers reported votes at the meeting of 25 Jun 2024. On say-on-pay, 8 of 109 filers that marked the item voted against management (7.3%).
Is this the result of the meeting?
No. The page counts the filers that report on Form N-PX, and the shares they reported. Fennec Pharmaceuticals Inc. reports the result of a vote on Form 8-K.
Why does the page show counts only for director elections?
A director record names the nominee. This site has no page and no row about a person. For director elections it keeps the number of nominees and the split of votes.

Provenance: SEC EDGAR, Form N-PX and N-PX/A filings that list Fennec Pharmaceuticals Inc. with a meeting date within three days of 25 Jun 2024. A proposal title is the most common wording among filers. Where a wording can name a person, the SEC category is shown. The filers wrote the filings. Filings read through .